Quadient annonce la nomination d'une nouvelle Directrice Marketing, Petra Wolf
02 janv. 2024 09h00 HE
|
QUADIENT
Quadient (Euronext Paris : QDT), un leader des solutions d’entreprise visant à faire de chaque interaction client – via un canal physique ou digital – une expérience riche et personnalisée, annonce la...
Quadient Announces Appointment of New Chief Marketing Officer, Petra Wolf
02 janv. 2024 09h00 HE
|
QUADIENT
Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, today announced the appointment of Petra Wolf as new Chief...
Future Electronics Announces New Executive Team
08 févr. 2023 07h46 HE
|
Future Electronics
MONTREAL, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Future Electronics today announced the further strengthening of its global executive team. Omar Baig, in addition to holding the positions of President...
Capgemini reinforces its focus on global industries and sustainability services with top leadership appointments
10 janv. 2023 02h30 HE
|
Capgemini SE
Press Relations:Sam ConnattyTel.: +44 370 904 3601Email: sam.connatty@capgemini.com Capgemini reinforces its focus on global industries and sustainability services with top leadership appointments ...
Capgemini renforce son approche sectorielle et ses services en matière de développement durable avec l’annonce de deux nominations
10 janv. 2023 02h30 HE
|
Capgemini SE
Press Relations:Victoire GRUXTel.: +33 6 04 52 16 55Email : victoire.grux@capgemini.com Capgemini renforce son approche sectorielle et ses services en matière de développement durable avec l’annonce...
ObsEva Announces Management Change
29 juil. 2022 01h00 HE
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – July 29, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel...
ObsEva Announces Corporate Updates
27 juil. 2022 00h55 HE
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – July 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel...
ObsEva Announces Appointment of Dr. Brandi Howard as Chief Clinical Officer
02 mai 2022 07h00 HE
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – May 2, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
ObsEva Announces Appointment of Dr. Brandi Howard as Chief Clinical Officer
02 mai 2022 01h00 HE
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – May 2, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer
30 sept. 2021 01h00 HE
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – September 30, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and...